[
  {
    "ts": null,
    "headline": "1 Healthcare Stock Worth Investigating and 2 to Ignore",
    "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six months, the industry has pulled back by 6.7%. This drop was discouraging since the S&P 500 held steady.",
    "url": "https://finnhub.io/api/news?id=230532293dc203b5b2561d4d6c9d117efe4e42f14d3f5dc5584cfdee5604620e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747370317,
      "headline": "1 Healthcare Stock Worth Investigating and 2 to Ignore",
      "id": 134499160,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COO",
      "source": "Yahoo",
      "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six months, the industry has pulled back by 6.7%. This drop was discouraging since the S&P 500 held steady.",
      "url": "https://finnhub.io/api/news?id=230532293dc203b5b2561d4d6c9d117efe4e42f14d3f5dc5584cfdee5604620e"
    }
  }
]